Explore the full directors' dealings record of CEGEDIM, a publicly traded company based in France. Shares trade on FR FR, under the supervision of AMF. Operating in the Technology sector, CEGEDIM has recorded 322 insider filings. Market capitalisation: €148.2m. The latest transaction was reported on 15 April 2026 — Acquisition. Among the most active insiders: FCB SAS. All data is free.
FY ended December 2025 · cache
25 of 322 declarations
Cegedim is a French technology and services group founded in 1969, historically positioned at the intersection of healthcare, software, and data-flow management. Listed on Euronext Paris under ISIN FR0000053506, the company has built its business over several decades around a strong specialization in digital solutions for healthcare professionals, pharmaceutical companies, health insurers, and, more broadly, enterprises that require industry-specific software and outsourced services. According to its 2024 Universal Registration Document, Cegedim is a French public limited company headquartered in Boulogne-Billancourt, and the group operates in more than 10 countries with nearly 6,500 employees as of 2025 and continuing activities revenue above €649 million in 2025. The group’s business model is built on several complementary operating lines. Cegedim Santé serves healthcare professionals with practice management software, online scheduling tools, drug databases, and prescription support solutions. Activities aimed at healthcare companies and pharmaceutical groups include databases, marketing intelligence, studies, and customer relationship management tools. Cegedim Business Services focuses on healthcare data flows and administrative processes, including data processing, digitalization, and certain business process outsourcing offerings. The group also develops software and services for human resources and complementary health insurance providers. In 2024, Cegedim generated €654.5 million in revenue, up 6.3% year on year, while recurring operating income rose to €39.5 million, representing a 6.0% margin versus 5.1% in 2023. This improvement reflects better operating profitability and a favorable scope effect, within a context of continued portfolio optimization and disciplined management of the business mix. Revenue remains largely driven by France, but the company also has a meaningful international footprint, particularly across Europe, with operations and subsidiaries in Belgium, Spain, the United Kingdom, Romania, and other markets where it maintains local activities or offshore delivery centers. Cegedim’s market position is that of a specialized, niche technology provider with recognized expertise in healthcare software and data-driven services. Its long operating history, deep regulatory know-how, and a meaningful share of recurring revenues are strategic strengths. For investors, the company offers exposure to the ongoing digital transformation of healthcare systems and enterprise services, with a business profile combining software, data, and outsourced workflows.